Features of the course of cardiovascular diseases against the background of COVID-19

Based on the analysis of 308 electronic medical records of patients with a confirmed diagnosis of a new coronavirus infection COVID-19, the features of the course of cardiovascular diseases at the regional level were studied. It was found that in patients with cardiovascular diseases, the severity of the course and mortality are higher than in patients without cardiac pathology.

Problem of Drug Interactions in the Treatment of Patients with COVID-19 and Comorbid Conditions

The article discusses the issues of drug interactions in the treatment of COVID-19 patients with concomitant cardiovascular diseases. It was revealed, that the most frequent comorbid background in patients with COVID-19 is cardiac pathology. Cardiac arrhythmias are observed in many cases, which can be aggravated by the proarrhythmogenic effect of drugs used to treat the novel coronavirus disease.